J Korean Ophthalmol Soc > Volume 57(4); 2016 > Article
Journal of the Korean Ophthalmological Society 2016;57(4):662-666.
DOI: https://doi.org/10.3341/jkos.2016.57.4.662    Published online April 15, 2016.
Phacoemulsification and Intraocular Lens Implantation after Unexpected Intralenticular Injection of a Dexamethasone Implant.
Jae Hyung Hwang, Jeong Hyun Lee, Jae Suk Kim
Department of Ophthalmology, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea. 991027js@hanmail.net
덱사메타손 삽입물의 수정체 내로의 주입 후 수술적 처치
황제형⋅이정헌⋅김재석
인제대학교 의과대학 상계백병원 안과학교실
Correspondence:  Jae Suk Kim
Received: 5 November 2015   • Revised: 10 January 2016   • Accepted: 16 February 2016
Abstract
PURPOSE
To report two cases of phacoemulsification and intraocular lens implantation after inadvertent intralenticular injection of a dexamethasone implant. CASE SUMMARY: (Case 1) A 73-year-old male was referred to our hospital after an accidental intralenticular injection of a dexamethasone implant in a local clinic for treatment of branch retinal vein occlusion in his right eye. During the follow-up period, posterior capsular opacity progressed and phacoemulsification and intraocular lens implantation were performed 10 days later. During the surgery, the dexamethasone implant shattered and could not be repositioned into the vitreous cavity. The remnants of that implant were removed and a second dexamethasone implant was successfully injected into the vitreous cavity. (Case 2) A 69-year-old female was being treated for branch retinal vein occlusion in her left eye in our hospital. A dexamethasone implant was accidentally injected into her lens, thus phacoemulsification and intraocular lens implantation were performed the following day. During the procedure, we were able to successfully reposition the dexamethasone implant into the vitreous cavity. CONCLUSIONS: Cataract formation after intralenticular injection of a dexamethasone implant can be easily managed with phacoemulsification. However, the dexamethasone implant shattered 10 days after the injection and could not be repositioned. The implant kept its hardness for at least one day and we were able to reposition it into the vitreous cavity without extending the rupture site of the posterior capsule.
Key Words: Dexamethasone implant;Intralenticular injection


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next